Interleukin-17 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-17 inhibitor, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice